Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

CorMedix Inc. (CRMD) Institutional Ownership & Insider Trading

193 institutions reported holding CorMedix Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 9 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CRMDCorMedix Inc.Follow CRMD — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
611.9M
P/E TTM
3.8
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

193 institutions held 56.5% of the shares. Across filers that reported both quarters, shares held changed +6.9%.

Increased+64New+25Decreased-52Closed-16

Largest moves, shares (millions)

Armistice Capital+0.5MBridgeway Capital Management+0.4MBlackRock+0.4MSculptor Capital-0.3MVictory Capital Management-0.3MKennedy Capital Management-0.3M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+1.6Sep 24+3.5Dec 24+0.5Mar 25+10.3Jun 25+9.2Sep 25-1.4Dec 25+0.1Mar 26+2.8Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2619344+6.9%64255216
Mar 2618441+0.4%51345645
Dec 2519842-3.2%76335225
Sep 2518743+27.2%84472827
Jun 2516934+44.1%60463113
Mar 2513523+2.1%48263217
Dec 2412923+18.3%4635229
Sep 2410119+11.4%35162215

CorMedix Inc. — questions

Who owns CorMedix Inc. stock?
193 institutions reported CorMedix Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.1%), Deep Track Capital, LP (8.1%), VANGUARD CAPITAL MANAGEMENT LLC (4.0%).
Are CorMedix Inc. insiders buying or selling?
9 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from CorMedix Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.